Delaware Business Court Insider | News
By Tom McParland | October 12, 2018
A federal appeals court upheld a Delaware judge's decision that invalidated four patents for Teva Pharmaceutical's Copaxone, clearing the way for competitors to bring generic versions of the company's multiple sclerosis drug to market.
Delaware Business Court Insider | News
By Tom McParland | October 2, 2018
The Delaware Court of Chancery on Monday allowed Fresenius SE to walk away from its planned $4.3 billion deal to acquire generic drugmaker Akorn Inc., ruling that a series of regulatory compliance issues at Akorn had allowed Fresenius to terminate the merger.
Delaware Business Court Insider | News
By Tom McParland | September 5, 2018
Genentech Inc. has accused Samsung Bioepis Co. in Delaware federal court of infringing 21 patents for its breast cancer drug Herceptin.
Delaware Business Court Insider | News
By Tom McParland | September 4, 2018
A Delaware federal judge has barred Amneal Pharmaceuticals from marketing a generic version of Galderma Laboratories' Oracea acne drug through 2025, finding that the drug infringed under the equitable doctrine of equivalents.
Delaware Business Court Insider | News
By Tom McParland | July 5, 2018
Investors in Pennsylvania-based AmerisourceBergen Corp. have sued in Delaware for access to books and records of the pharmaceutical firm, stating that they are considering launching a civil lawsuit over a scheme by its subsidiaries to skim and repackage cancer drugs for sale across the country.
Delaware Business Court Insider | News
By Tom McParland | June 6, 2018
A Delaware federal judge on Tuesday upheld the validity of Shire Orphan Therapies' patent for Firazyr, blocking a Germany-based pharma company from launching a planned generic version of the anti-inflammatory drug until 2019.
Delaware Business Court Insider | News
By Tom McParland | June 5, 2018
A federal judge in Delaware has ordered AbbVie Inc. to turn over documents related to Boehringer Ingelheim's defense of unclean hands in a case accusing the German drugmaker of infringing 74 patents with a biosimilar version of AbbVie's immunosuppressant Humira.
Delaware Business Court Insider | News
By Tom McParland | May 15, 2018
GlaxoSmithKline is appealing a Delaware federal district judge's ruling that wiped out a $235 million verdict against Teva Pharmaceuticals for allegedly infringing a patent for the hypertension drug Coreg.
By Charles Toutant | May 3, 2018
Litigation over generic drug applications under the Abbreviated New Drug Application process increased 30 percent in 2017, according to a report by litigation analytics company Lex Machina.
Delaware Business Court Insider | News
By Tom McParland | April 4, 2018
Indivior on Tuesday sued to block a rival drugmaker from bringing a generic version of an under-the-tongue form of Suboxone to market, after being dealt a stinging loss last month in an ongoing effort to protect its top-selling drug.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS